logo

For the Inventor, By the Inventor

Andover, MA, United States of America

Rajiv Chopra

This inventor holds 4 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Novartis Ag, American Home Products Corporation, Millennium Pharmaceuticals Limited. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajiv Chopra. Retrieved from https://idiyas.com/inventor/rajiv-chopra-7cbfvpg4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Belmont, MA (US) (2009)
  • Andover, MA (US) (2006 - 2022)

Company Filing History:

goldMedal2 out of 3,978 
 
Novartis Ag
 patents
silverMedal1 out of 1,567 
 
American Home Products Corporation
 patents
bronzeMedal1 out of 855 
 
Millennium Pharmaceuticals Limited
 patents
4. 1 out of 1,309 
 
Wyeth
 patents
where one patent can have more than one assignee

Years Active: 2006-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 11312766 - Antibodies against growth differentiation factor 15 and uses thereof (2022-04-26),
2. 8324239 - Furopyridine compounds and uses thereof (2012-12-04),
3. 7630838 - Method for identifying agents that interact with beta-site APP cleaving enzyme (BACE) (2009-12-08),
4. 7155346 - Crystal structure of yqeJ and uses thereof (2006-12-26),

Title: Rajiv Chopra: Innovator in Biopharmaceuticals

Introduction

Rajiv Chopra is a notable inventor based in Andover, MA (US), recognized for his contributions to the field of biopharmaceuticals. With a total of 4 patents to his name, he has made significant strides in developing innovative therapeutic solutions.

Latest Patents

Among his latest patents, Chopra has developed monoclonal antibodies that target human Growth Differentiation Factor 15 (GDF15). This invention includes pharmaceutical compositions and methods of treatment that utilize these antibodies. Additionally, he has created furopyridine compounds, which encompass a method for manufacturing these compounds and their therapeutic applications. This patent also includes a combination of pharmacologically active agents and a pharmaceutical composition.

Career Highlights

Throughout his career, Rajiv Chopra has worked with prominent companies such as Novartis AG and American Home Products Corporation. His work in these organizations has contributed to advancements in drug development and therapeutic methodologies.

Collaborations

Chopra has collaborated with several professionals in his field, including Mark L. Stahl and Kristine Svenson. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Rajiv Chopra's work in biopharmaceuticals exemplifies the importance of innovation in healthcare. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…